| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $24.4M | +16.3% |
| Cost of Revenue | $36.3M | +37.9% |
| Gross Profit | -$11.8M | -123.3% |
| R&D Expense | $9.6M | +211.2% |
| SG&A Expense | $51.6M | +20.5% |
| Operating Income | -$73.1M | -42.6% |
| Interest Expense | $15.0M | +11.9% |
| Income Tax | $0 | — |
| Net Income | $15.2M | +115.1% |
| EPS (Basic) | $0.20 | +112.0% |
| EPS (Diluted) | $0.16 | +109.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $56.0M | -66.8% |
| Accounts Receivable | $9.9M | +7.9% |
| Inventory | $47.1M | +221.9% |
| Current Assets | $122.4M | -38.6% |
| Total Assets | $143.6M | -32.7% |
| Current Liabilities | $15.9M | +10.6% |
| Long-term Debt | $62.1M | -2.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$104.5M | -58.8% |
| Capital Expenditures | $7.9M | +144.1% |
| Investing Cash Flow | -$7.9M | -148.3% |
| Financing Cash Flow | -$85K | -100.0% |
| Free Cash Flow | -$112.4M | -62.8% |
| Total Liabilities |
| $89.0M |
| -52.7% |
| Stockholders' Equity | $54.6M | +116.4% |